Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d21cbff64022f95c237c0bd3ec8656ca http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b4bd57cf0ca16521f9d901b143880ae |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
filingDate |
2007-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2a9bf3b3965b5127c30b311b45c9f36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49d97ce32de434ad6e9a3a0b597f6de0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56433d76590625ae563fe4d7eee6158e |
publicationDate |
2007-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2650129-A1 |
titleOfInvention |
Method of measuring residual cancer and predicting patient survival |
abstract |
Disclosed is a method for determining survival and relapse of a patient undergoing therapy for a tumor by determining a residual cancer burden index based on the bidimensional diameters of a primary tumor bed of said tumor in a resection specimen, the proportion of the primary tumor bed area that contains invasive carcinoma, the number of regional lymph nodes containing metastatic carcinoma, the diameter of the largest metastasis in an regional lymph node; and the fractional reduction in lymph node size with each added positive lymph node. |
priorityDate |
2006-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |